PMID- 19181966 OWN - NLM STAT- MEDLINE DCOM- 20090409 LR - 20211020 IS - 0363-6135 (Print) IS - 1522-1539 (Electronic) IS - 0363-6135 (Linking) VI - 296 IP - 3 DP - 2009 Mar TI - Restoration of contractility in hyperhomocysteinemia by cardiac-specific deletion of NMDA-R1. PG - H887-92 LID - 10.1152/ajpheart.00750.2008 [doi] AB - Homocysteine (HCY) activated mitochondrial matrix metalloproteinase-9 and led to cardiomyocyte dysfunction, in part, by inducing mitochondrial permeability (MPT). Treatment with MK-801 [N-methyl-d-aspartate (NMDA) receptor antagonist] ameliorated the HCY-induced decrease in myocyte contractility. However, the role of cardiomyocyte NMDA-receptor 1 (R1) activation in hyperhomocysteinemia (HHCY) leading to myocyte dysfunction was not well understood. We tested the hypothesis that the cardiac-specific deletion of NMDA-R1 mitigated the HCY-induced decrease in myocyte contraction, in part, by decreasing nitric oxide (NO). Cardiomyocyte-specific knockout of NMDA-R1 was generated using cre/lox technology. NMDA-R1 expression was detected by Western blot and confocal microscopy. MPT was determined using a spectrophotometer. Myocyte contractility and calcium transients were studied using the IonOptix video-edge detection system and fura 2-AM loading. We observed that HHCY induced NO production by agonizing NMDA-R1. HHCY induced the MPT by agonizing NMDA-R1. HHCY caused a decrease in myocyte contractile performance, maximal rate of contraction and relaxation, and prolonged the time to 90% peak shortening and 90% relaxation by agonizing NMDA-R1. HHCY decreased contraction amplitude with the increase in calcium concentration. The recovery of calcium transient was prolonged in HHCY mouse myocyte by agonizing NMDA-R1. It was suggested that HHCY increased mitochondrial NO levels and induced MPT, leading to the decline in myocyte mechanical function by agonizing NMDA-R1. FAU - Moshal, Karni S AU - Moshal KS AD - Dept. of Physiology and Biophysics, 500 S. Preston St., HSC Bldg. A-1115, Univ. of Louisville, Louisville, KY 40202, USA. FAU - Kumar, Munish AU - Kumar M FAU - Tyagi, Neetu AU - Tyagi N FAU - Mishra, Paras K AU - Mishra PK FAU - Metreveli, Naira AU - Metreveli N FAU - Rodriguez, Walter E AU - Rodriguez WE FAU - Tyagi, Suresh C AU - Tyagi SC LA - eng GR - HL-71010/HL/NHLBI NIH HHS/United States GR - HL-74185/HL/NHLBI NIH HHS/United States GR - HL-88012/HL/NHLBI NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't DEP - 20090130 PL - United States TA - Am J Physiol Heart Circ Physiol JT - American journal of physiology. Heart and circulatory physiology JID - 100901228 RN - 0 (Mitochondrial Membrane Transport Proteins) RN - 0 (Mitochondrial Permeability Transition Pore) RN - 0 (NR1 NMDA receptor) RN - 0 (Reactive Oxygen Species) RN - 0 (Receptors, N-Methyl-D-Aspartate) RN - 31C4KY9ESH (Nitric Oxide) SB - IM MH - Animals MH - Calcium Signaling MH - Disease Models, Animal MH - Hyperhomocysteinemia/metabolism/*physiopathology MH - Mice MH - Mice, Knockout MH - Mitochondria, Heart/metabolism MH - Mitochondrial Membrane Transport Proteins/metabolism MH - Mitochondrial Permeability Transition Pore MH - *Myocardial Contraction MH - Myocytes, Cardiac/*metabolism MH - Nitric Oxide/metabolism MH - Oxidative Stress MH - Reactive Oxygen Species/metabolism MH - Receptors, N-Methyl-D-Aspartate/*deficiency/genetics PMC - PMC2660230 EDAT- 2009/02/03 09:00 MHDA- 2009/04/10 09:00 PMCR- 2010/03/01 CRDT- 2009/02/03 09:00 PHST- 2009/02/03 09:00 [entrez] PHST- 2009/02/03 09:00 [pubmed] PHST- 2009/04/10 09:00 [medline] PHST- 2010/03/01 00:00 [pmc-release] AID - 00750.2008 [pii] AID - H-00750-2008 [pii] AID - 10.1152/ajpheart.00750.2008 [doi] PST - ppublish SO - Am J Physiol Heart Circ Physiol. 2009 Mar;296(3):H887-92. doi: 10.1152/ajpheart.00750.2008. Epub 2009 Jan 30.